Help | RSS Feed

Novelion Therapeutics, Inc. (NASD:NVLNF) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Novelion Therapeutics, Inc. (NASD:NVLNF) seasonal charts above shows that a Buy Date of November 24 and a Sell Date of February 17 has resulted in a geometric average return of 7.33% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 35.33% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Novelion Therapeutics Inc is a biopharmaceutical company. It is engaged in developing patient care facility and providing services for people suffering from rare diseases like lipodystrophy, leber congenital amaurosis, and retinitis pigmentosa. Novelion, Aegerion, JUXTAPID, LOJUXTA, MYALEPT and MYALEPTA are the registered trademarks of the company.

To download NVLNF seasonal chart data, please log in or Subscribe.


Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...
Seasonal Advantage Portfolio by CastleMoore